Moreover, MALAT1 expression data in TCGA database were analyzed using the online tool, GEPIA [28], and we found that HCC patients with MALAT1high tumors had shorter disease free survival (DFS) times compared to those with MALAT1low tumors (p = 0.014; Figure 1B). This evidence concerns the gene MALAT1 and hepatocellular carcinoma.